The Parenteral Drug Association (PDA) today announced the winners of the 2021 PDA Drug Delivery Innovation Awards during the opening plenary session of the 2021 PDA Universe of Pre-Filled Syringes and Injection Devices. Awardees were recognized for their technical innovations in advancing the field of bio/pharmaceutical manufacturing.
The Innovation Award is presented to Roche Genentech for the Port Delivery System with ranibizumab. The drug delivery device is an innovative, investigational, permanent, indwelling, ocular delivery system that includes a surgically placed implant for continuous delivery of a customized formulation of ranibizumab into the vitreous. After implantation, the device uses a refill exchange process to replenish the fresh drug.
The Partnership Innovation Award is presented to Syntegon Technology GmbH and Vetter Pharma-Fertigung GmbH & Co. KG for the Versynta microBatch, an innovative system based on a gloveless isolator cell with a versatile robot, responsible for filling, line set-up and environmental monitoring. With the focus on flexibility, a broad range of pre-sterilized packaging components including pre-filled syringes either made of glass or plastic can be handled. A comprehensive monitoring system and 100% fill weigh checks allow a continuous process control.
“I want to congratulate the companies that won the 2021 PDA Drug Delivery Innovation Awards and all the companies that were considered for this award,” said Richard Johnson, PDA President & CEO. “PDA has seen continued growth and visibility of these important awards since they were launched in 2019.”